Virtuix Q1FY27 sales beat estimates, gross margin expands to 30%

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights

Virtuix Holdings reported Q1FY27 sales of $767.300K, beating estimates. Gross margin expanded to 30% from 17% due to higher pricing. New orders rose 72% YoY. The company faces a widened net loss due to public company costs and non-cash charges, with a cash burn of ~$1M/month.

powered bylight_fuzz_icon
48721269

*this image is generated using AI for illustrative purposes only.

Virtuix Holdings Inc. (NASDAQ: VTIX) reported first quarter fiscal year 2027 results that exceeded analyst expectations, with net sales reaching $767.300K against an estimate of $535.667K. The company also posted a net loss per share of ($0.22), beating the consensus estimate of a ($0.24) loss. The improved top-line performance reflects a strategic shift from backlog clearance to new customer acquisition, despite the completion of the final batch of legacy Omni One orders accumulated since August 2023.

Despite the lower top line compared to the prior year, unit economics improved significantly. Gross profit rose 29% to $227,158 from $176,077 in the prior-year period, driving gross margin expansion to 30% from 17%. This improvement was primarily attributed to higher selling prices for the complete Omni One system compared to units delivered in the previous year. Management noted that pricing for the complete system increased from $2,595 to $3,495 in November of the prior year, while new products like Omni One for Quest are priced at $2,595.

Operational Highlights

New order momentum accelerated during the quarter:

  • New orders for Omni One systems increased 72% year-over-year.
  • Orders have risen approximately 150% since the launch of Omni One for Quest, a trend continuing into the current quarter.
  • The company secured its first Omni One Enterprise sale to Tesla Inc. for humanoid robot teleoperation.
  • Defense sector advancements include the U.S. Marine Corps Infantry Fireteam Trainer pilot delivery expected in Q4 2026 and an SBIR Phase I award from the U.S. Air Force.

Financial Performance

The bottom line was pressured by increased operating costs and non-cash charges. Total operating expenses rose 86% to $4.1 million from $2.2 million, driven by a $0.7 million increase in stock-based compensation and $1.2 million in professional services fees related to public company operations. Other expenses surged to $3.2 million from $0.2 million, largely due to $2.5 million in interest expense and amortization of debt discount on convertible notes. Approximately $4 million of the net loss consisted of non-cash charges.

Metric: Q1FY27 Q1FY26 Change
Net Sales: $0.8 million $1.0 million -26%
Gross Profit: $227,158 $176,077 +29%
Gross Margin: 30% 17% +13 pts
Operating Expenses: $4.1 million $2.2 million +86%
Net Loss: ($7.2) million ($2.3) million Widened
Adjusted EBITDA Loss: ($3.1) million ($1.9) million Widened

Net loss per share narrowed to ($0.22) from ($0.28). Cash and cash equivalents stood at $7.4 million as of June 30, 2026, down from $9.5 million at March 31, 2026. Management indicated a cash burn run rate of approximately $1 million per month, elevated due to public company costs. Inventory increased to $1.4 million as the company builds for order growth. Total liabilities were $15.7 million, including $10.7 million of notes payable, net of discount.

Strategic Outlook

Management outlined six priorities for the coming periods:

  1. Accelerate consumer revenue growth through the Meta collaboration.
  2. Advance defense programs towards larger awards, including moving Air Force SBIR Phase I to Phase II.
  3. Pursue M&A in defense, targeting acquisitions with $10 million to $50 million in annual revenue.
  4. Expand enterprise sales, building on traction with Tesla and NASA.
  5. Build out healthcare and therapeutics verticals via partnerships with Sirica Therapeutics.
  6. Drive toward profitability, leveraging the improved 30% gross margin.

Production capacity is established at up to 3,000 units per month, translating to approximately $100 million in annual revenues. The company aims to bundle Omni One for Quest with Meta headsets for the holiday season.

What the Numbers Show

The divergence between revenue decline and gross profit growth highlights a pricing-driven margin expansion rather than volume-led growth. With gross profit rising 29% despite a 26% revenue drop, the company is realizing significantly higher value per unit sold. However, this operational improvement was insufficient to offset the 86% surge in operating expenses and substantial non-cash interest charges, resulting in a widened net loss. The cash burn of approximately $2 million in the quarter underscores the need for continued capital efficiency or financing as the company transitions from backlog fulfillment to new customer acquisition.

Given the current cash burn rate of $1 million per month and $7.4 million in cash reserves, what is Virtuix's timeline for reaching cash-flow positivity or requiring additional capital raising?

How might the strategic M&A focus on defense companies with $10M-$50M in revenue impact Virtuix's debt load and integration costs in the near term?

Will the bundling of Omni One for Quest with Meta headsets during the holiday season significantly alter the company's gross margin profile compared to standalone sales?

like17
dislike

Virtuix delays Q1FY27 results to Aug 19; CEO to present at Sidoti

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights

Virtuix Holdings delays Q1FY27 results to August 19 for auditor review by EisnerAmper. CEO Jan Goetgeluk will present at the Sidoti Micro-Cap Virtual Investor Conference on August 20, highlighting expansion in defense, robotics, and healthcare sectors alongside consumer growth.

powered bylight_fuzz_icon
48116581

*this image is generated using AI for illustrative purposes only.

Virtuix Holdings Inc. (NASDAQ: VTIX) has rescheduled the release of its first quarter fiscal year 2027 financial results and the associated earnings conference call to provide additional time for its newly appointed independent registered public accounting firm, EisnerAmper LLP, to complete its review. The company will file its Quarterly Report on Form 10-Q after market close on Wednesday, August 19, 2026, with the conference call moving to Thursday, August 20, 2026, at 8:30 am Eastern time.

The postponement utilizes an extension period granted under Rule 12b-25 of the Securities Exchange Act of 1934. This regulatory mechanism allows issuers to file periodic reports up to 15 calendar days late without penalty, provided they disclose the reason for the delay. Virtuix stated that the extra time is necessary for EisnerAmper to finalize its review procedures regarding the interim financial statements and related disclosures following the firm's engagement in early August.

Reason for Rescheduling

The delay is strictly procedural, stemming from the transition to a new audit firm rather than any underlying financial or operational issues. Virtuix explicitly clarified that the rescheduling is not due to any disagreement with its accounting firm, nor does it anticipate any restatement of previously issued financial statements. Furthermore, the company affirmed that there is no change to its previously communicated business outlook.

Jan Goetgeluk, Chairman and CEO of Virtuix, explained that the engagement with EisnerAmper began in early August. "We’re giving EisnerAmper a few extra days to complete their review of our interim financial statements, and we look forward to reporting our results next week," Goetgeluk said.

Sidoti Investor Conference Presentation

In addition to the earnings release, Virtuix announced that Founder, Chief Executive Officer, and Chairman Jan Goetgeluk will present at Sidoti’s Micro-Cap Virtual Investor Conference on Thursday, August 20, 2026. The presentation will highlight recent developments including the Company’s expansion of Omni One within the Meta Quest ecosystem, humanoid robotics applications with Tesla, Counter-UAS training for the U.S. Marine Corps, and the growing use of Virtuix’s technology in healthcare applications.

Mr. Goetgeluk will meet with institutional investors and host a presentation on Thursday, August 20, 2026 at 10:00 a.m. Eastern Time, followed by a question-and-answer session. This follows the rescheduled earnings conference call earlier that morning at 8:30 am Eastern Time.

"Omni One continues to gain traction well beyond its original consumer market, positioning Virtuix for long-term growth," said Jan Goetgeluk. "We look forward to discussing these developments with investors, together with the broader commercial progress we’re seeing across our consumer, defense, and enterprise markets."

Management expects the presentation to provide investors with additional insight into Virtuix’s accelerating consumer growth and expanding commercial strategy across enterprise XR, defense simulation, healthcare, and robotics. Virtuix will also host virtual one-on-one meetings with investors on Wednesday and Thursday, August 19-20, 2026.

Event Schedule

Detail Information
Earnings Call Date: Thursday, August 20, 2026
Earnings Call Time: 8:30 am Eastern time
Sidoti Presentation Date: Thursday, August 20, 2026
Sidoti Presentation Time: 10:00 a.m. Eastern Time
Presenter: Jan Goetgeluk, CEO
U.S. Dial-in: 1-877-425-9470
International Dial-in: 1-201-389-0878
Conference ID: 13761831

A telephone replay of the earnings call will be available approximately three hours after the event and will remain accessible through Thursday, September 3. Investors can access the replay by dialing 1-844-512-2921 (U.S.) or 1-401-231-7667 (international) and entering PIN 13761831. A webcast replay will also be hosted on the company’s investor relations website.

About Virtuix

Virtuix Holdings Inc. is a manufacturer of AI-driven, full-body simulation systems serving consumer, enterprise, defense, healthcare, and research markets. The company’s flagship "Omni" omni-directional treadmills allow users to walk and run in 360 degrees within AI-generated environments. With applications in immersive entertainment, defense training, and enterprise solutions, Virtuix focuses on advancing full-body XR and AI-driven immersive experiences globally.

How might the transition to EisnerAmper impact Virtuix's future reporting timelines or investor confidence in financial transparency?

What specific revenue milestones does Virtuix expect to achieve through its newly highlighted partnerships with Tesla and the U.S. Marine Corps?

Will the expansion of Omni One within the Meta Quest ecosystem lead to increased hardware sales or primarily drive software and service revenue?

like19
dislike

More News on Virtuix Holdings Inc